Unicancer
Romain Mignerat is a seasoned professional in health diplomacy and international partnerships, currently serving as the Responsable des affaires européennes et internationales at Unicancer since November 2024. Prior experience includes the role of Partnership Manager at ANRS Maladies infectieuses émergentes, where Romain Mignerat developed health diplomacy actions and established cooperation agreements to enhance pandemic preparedness primarily in the Global South. Previous positions include Deputy Head of Campus France China, managing the Beijing office's operations and strategic direction, and Policy Officer roles at both the French Embassy in China and the European Small Business Alliance. Academic qualifications include a Master's Degree in European Affairs from Sciences Po Toulouse and a Bachelor's Degree in Chinese Language and Culture from Université Paris Cité, among others.
This person is not in any teams
Unicancer
UNICANCER groups together the 20 French Comprehensive Cancer Centres (FCCCs) which are private, not-for-profit hospitals located across the French territory. FCCCs are dedicated to fighting cancer through a threefold mission of patient care, research and education. They contribute to the public hospital service in accordance with statutory fees, with no additional charge. UNICANCER is one of the largest cancer care and research organisations in Europe. Via its R&D department, it sponsors clinical trials to improve cancer patients’ care and access to innovation, particularly in areas neglected by the pharmaceutical industry. UNICANCER is accredited by the French Ministry of Health and is eligible for public grants. The French Comprehensive Cancer Centres in numbers: • 20 sites located throughout the French territory • 19,000 employees • >135,000 patients hospitalised each year • Approximately 500 active clinical trials • 17% of the patients treated are included in a clinical trial (vs an average of 8.5% of cancer patients in France) • 19 molecular biology platforms certified by the French National Cancer Institute • 7 integrated cancerology research sites (SIRIC) certified by the French NCI (out of 8) • 12 early-phase clinical trial Centres (CLIP²) certified by the French NCI (out of 16) • 5th for global publications in oncology • 32% of French publications in oncology (articles in which FCCCs have participated) UNICANCER sponsors • 76 ongoing clinical trials (2016) • Including 5400 patients (2016) • From 270 investigator sites (2015), • With 20% located in other European countries